Tumor and immune cell imaging based on PD-L1 expression

摘要

The presently disclosed subject matter provides compositions, kits, and methods that include contrast agents capable of detecting programmed death ligand 1 (PD-L1). The contrast agents of the present disclosure can be used to detect diseases and disorders such as cancer, infections, and inflammation in a subject.